On the morning of March 7, 2023, a delegation led by Xu Hao, Deputy Director of the Songjiang District Economic Commission, and Zhang Yanzhi, Deputy Director of the Economic Commission of Songjiang District, visited ConFlow MedTech for on-the-spot research and guidance. Xiao Yue, from the Technical Progress Section of the Economic Commission of Songjiang District and the District Science and Technology Committee, coordinated the visit. Chen Xiumin, Founder and General Manager of ConFlow MedTech, and the company's team warmly welcomed the delegation and conducted a productive exchange forum.
District Economic Commission and Science and Technology Commission leaders were informed that ConFlow MedTech, an enterprise with over two years of establishment, has applied for over 60 patents, including those for invention, utility models, appearance design, PCT, and foreign patents. Moreover, three products are in various stages of clinical trial development, demonstrating organized progress in their R&D. The leaders commended ConFlow MedTech's prowess in independent R&D innovation and the smooth advancement of its projects. They also offered expert guidance for the application process, highlighting the importance of specialization, refinement, distinctiveness, innovation, and high-tech orientation for enterprises.
After the meeting, the leaders of the District Economic Commission and the Science and Technology Commission, accompanied by General Manager Chen Xiumin, toured ConFlow MedTech's R&D laboratories, machining platforms, and clean workshops meeting ISO 10000 standards. The leaders positively commended ConFlow MedTech's robust R&D, production processes, equipment, and factory management, as well as the effective operation of its quality management system. They expressed their confidence and high expectations for ConFlow MedTech's future development, noting its rapid and steady growth, continuous expansion of the enterprise, and ongoing enhancements in R&D innovation capabilities. They believe that ConFlow MedTech holds significant potential to advance innovative cardiovascular solutions for patients, both domestically and internationally.
After the meeting, the leaders of the District Economic Commission and the Science and Technology Commission, accompanied by General Manager Chen Xiumin, toured ConFlow MedTech's R&D laboratories, machining platforms, and clean workshops meeting ISO 10000 standards. The leaders positively commended ConFlow MedTech's robust R&D, production processes, equipment, and factory management, as well as the effective operation of its quality management system. They expressed their confidence and high expectations for ConFlow MedTech's future development, noting its rapid and steady growth, continuous expansion of the enterprise, and ongoing enhancements in R&D innovation capabilities. They believe that ConFlow MedTech holds significant potential to advance innovative cardiovascular solutions for patients, both domestically and internationally.
- Previous article：The launch meeting for the clinical trial of ConFlow MedTech's new TriFlower foramen ovale obturator was a success.
- Next article：ConFlow MedTech has achieved further recognition in the medical field, securing the 2022 Development Progress Award and Outstanding Enterprise Award in Xinqiao Town, Songjiang District, Shanghai.
-
September 17,2021Celebrating its one-year milestone, ConFlow MedTech successfully concluded its first-anniversary event, joined by supporters and partners.
-
July 24,2023Good News | ConFlow MedTech was awarded as "Specialized and Sophisticated SME" in Shanghai City
-
September 18,2023Thank you for being with us as we celebrate the third anniversary of ConFlow MedTech's establishment!
Pursue further excellence!
